Covered recipient · General Payments record
MICHAEL FRANK HAMANT
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2020
$1,480.91
- Reported across 45 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2020 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $343.28 | 17 |
By paying entity
PY2020 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $131.74 | 3 |
| Amgen Inc. | $53.95 | 3 |
| Exeltis, USA Inc. | $40.56 | 3 |
| TherapeuticsMD, Inc. | $30.26 | 2 |
| MILLICENT US INC | $16.01 | 1 |
| ABBVIE INC. | $15.28 | 1 |
| SANOFI PASTEUR INC. | $14.84 | 1 |
| EISAI INC. | $14.73 | 1 |
| Amarin Pharma Inc. | $13.09 | 1 |
| Hologic Sales and Service, LLC | $12.82 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2020 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| AbbVie Inc. | $15.28 | 09/22/2020 | Food and Beverage | Undisputed | 01/23/2026 | 721852617 | CMS |
| Amarin Pharma Inc. | $13.09 | 07/08/2020 | Food and Beverage | Undisputed | 01/23/2026 | 740079023 | CMS |
| Amgen Inc. | $14.92 | 01/15/2020 | Food and Beverage | Undisputed | 01/23/2026 | 741227611 | CMS |
| Amgen Inc. | $17.98 | 04/09/2020 | Food and Beverage | Undisputed | 01/23/2026 | 741227613 | CMS |
| Amgen Inc. | $21.05 | 10/21/2020 | Food and Beverage | Undisputed | 01/23/2026 | 741227615 | CMS |
| Eisai Inc. | $14.73 | 09/04/2020 | Food and Beverage | Undisputed | 01/23/2026 | 751223217 | CMS |
| Exeltis, USA Inc. | $13.59 | 08/13/2020 | Food and Beverage | Undisputed | 01/23/2026 | 751335867 | CMS |
| Exeltis, USA Inc. | $15.98 | 10/07/2020 | Food and Beverage | Undisputed | 01/23/2026 | 751335865 | CMS |
| Exeltis, USA Inc. | $10.99 | 12/08/2020 | Food and Beverage | Undisputed | 01/23/2026 | 751335869 | CMS |
| GlaxoSmithKline, LLC. | $121.83 | 02/12/2020 | Food and Beverage | Undisputed | 01/23/2026 | 738572787 | CMS |
| GlaxoSmithKline, LLC. | $5.05 | 09/18/2020 | Food and Beverage | Undisputed | 01/23/2026 | 738611365 | CMS |
| GlaxoSmithKline, LLC. | $4.86 | 10/13/2020 | Food and Beverage | Undisputed | 01/23/2026 | 738895465 | CMS |
| Hologic, LLC | $12.82 | 06/17/2020 | Food and Beverage | Undisputed | 01/23/2026 | 713511711 | CMS |
| MILLICENT US INC | $16.01 | 06/03/2020 | Food and Beverage | Undisputed | 01/23/2026 | 721510663 | CMS |
| SANOFI PASTEUR INC. | $14.84 | 03/04/2020 | Food and Beverage | Undisputed | 01/23/2026 | 744033629 | CMS |
| TherapeuticsMD, Inc. | $13.27 | 07/09/2020 | Food and Beverage | Undisputed | 01/23/2026 | 745691721 | CMS |
| TherapeuticsMD, Inc. | $16.99 | 09/23/2020 | Food and Beverage | Undisputed | 01/23/2026 | 745691723 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020
- Generated from
- OP_DTL_GNRL_PGYR2020_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.